DRIO

DarioHealth Corp.

NasdaqAdd to watchlist

Healthcare · Diagnostics & Research

$7.20

+$0.21+3.00%

Delayed · 2026-09-18T20:00:00.000Z · marketstack

Aug 24, 2026$7.20

−$0.01−0.14%over 1M

Session

Day range100% of range

$7.03$7.20

Fundamentals

Visualize fundamentals and more

Market cap: 67.27M
P/E ratio: -

Revenue grew −17.31% in FY2025, +26.18% slower than its sector. The median across Healthcare companies this platform tracks is +8.87%.

Risk factors, year on year

Item 1AMar 2026 10-KMar 2025

added: 66
dropped: 94
re-drafted: 44

Out of 167 passages in this year’s Item 1A.

New this year

According to our management’s estimates, based on our current cash on hand and further based on our budget and the assumption related to our commercial sales, we believe that we will have sufficient resources to continue our activities for at least a period …

159 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

The Middle East
FDA approval
Litigation
Reimbursement
Currency moves
Debt covenants
Cybersecurity
Export controls

And 13 more.

The Middle East
To date, we have received regulatory authorization in Australia, Canada, Israel and the United States. 43 Table of Contents The research, design, testing, manufacturing, labeling, selling, marketing and distribution of medical devices are subject to extensive …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

16 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 18, 2026 · the last close

DarioHealth Corp. investor relations

What DRIO has filed with the SEC. This is not DarioHealth Corp.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like DarioHealth Corp.

Also filed under Diagnostics & Research, ranked by how closely they sit beside DRIO.

TMOThermo Fisher Scientific Inc.compare with DRIO
ILMNILLUMINA, Inc.compare with DRIO
DHRDanaher Corp.

TWSTTwist Bioscience Corpcompare with DRIO

AAgilent TECHNOLOGIES, Inc.compare with DRIO

Ask about DarioHealth Corp.

The assistant answers from what DRIO has actually filed: 14 annual reports filed with the SEC and 1 Form 4 filing from the last year. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from DRIO's filings and figures. One a day without an account; a free account has its own, and no card.

See how much of DarioHealth Corp. each of these investors holds, and every quarter they moved.

Ten seconds. No card. Nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with DarioHealth Corp.

Be told the moment a DRIO insider trades
Put DarioHealth Corp. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
DarioHealth Corp.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about DarioHealth Corp.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

Risk factors, year on year

Item 1AMar 2026 10-KMar 2025

added: 66
dropped: 94
re-drafted: 44

Out of 167 passages in this year’s Item 1A.

New this year

According to our management’s estimates, based on our current cash on hand and further based on our budget and the assumption related to our commercial sales, we believe that we will have sufficient resources to continue our activities for at least a period …

159 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

The Middle East
FDA approval
Litigation
Reimbursement
Currency moves
Debt covenants
Cybersecurity
Export controls

And 13 more.

The Middle East
To date, we have received regulatory authorization in Australia, Canada, Israel and the United States. 43 Table of Contents The research, design, testing, manufacturing, labeling, selling, marketing and distribution of medical devices are subject to extensive …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add